MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MYGN on Nasdaq
CUSIP
62855J104
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
93.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
88.5M
Holdings value
$640M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
212
Number of buys
110
Number of sells
-107
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.3% $74.9M 14.1M BlackRock, Inc. Jun 30, 2025
VANGUARD GROUP INC 8.47% -15.7% $57M -$9.94M 7.88M -14.9% The Vanguard Group Sep 30, 2025
INTEGRATED CORE STRATEGIES (US) LLC 5.1% -4% $34.3M -$1.28M 4.75M -3.58% Millennium Management LLC Sep 30, 2025
BARCLAYS PLC 4.23% -21.6% $28.5M -$6.95M 3.94M -19.6% Barclays PLC Sep 30, 2025
Camber Capital Management LP 3.41% $22.3M 3.1M Camber Capital Management LP Dec 31, 2024
DISCIPLINED GROWTH INVESTORS INC /MN 0.8% -86% $4.24M -$19.9M 754K -82.4% DISCIPLINED GROWTH INVESTORS INC /MN Jun 30, 2025

Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 88.5M $640M +$7.18M $7.23 212
2025 Q2 90.5M $481M -$73.9M $5.31 216
2025 Q1 94M $833M +$10.2M $8.87 226
2024 Q4 92.4M $1.27B -$38.6M $13.71 215
2024 Q3 90.7M $2.48B -$47M $27.39 242
2024 Q2 92.3M $2.26B -$38.8M $24.46 222
2024 Q1 93.8M $2B +$85.6M $21.32 185
2023 Q4 89.9M $1.72B +$139M $19.14 192
2023 Q3 82.7M $1.33B +$18.8M $16.04 183
2023 Q2 81.1M $1.88B -$25.4M $23.18 183
2023 Q1 82.2M $1.91B +$45.2M $23.23 186
2022 Q4 80.5M $1.17B -$18.9M $14.51 190
2022 Q3 81.5M $1.55B +$26.2M $19.08 185
2022 Q2 79.9M $1.45B +$19.1M $18.17 188
2022 Q1 78.9M $1.99B +$13.4M $25.20 199
2021 Q4 78.3M $2.16B -$41.8M $27.60 193
2021 Q3 79.3M $2.56B +$122M $32.29 211
2021 Q2 75.5M $2.31B +$49.3M $30.58 199
2021 Q1 73.9M $2.25B -$35.1M $30.45 193
2020 Q4 75M $1.48B +$38M $19.78 178
2020 Q3 78.4M $1.02B +$20M $13.04 186
2020 Q2 72.9M $827M -$35.2M $11.34 190
2020 Q1 73.5M $1.05B -$123M $14.31 182
2019 Q4 78.8M $2.15B +$33.4M $27.23 222
2019 Q3 77.5M $2.22B +$28.1M $28.63 220
2019 Q2 76.9M $2.13B -$66.2M $27.78 234
2019 Q1 78.6M $2.61B +$98.3M $33.20 259
2018 Q4 76.3M $2.22B +$6.25M $29.07 259
2018 Q3 75.4M $3.47B +$112M $46.00 281
2018 Q2 73.3M $2.74B -$57.2M $37.37 250
2018 Q1 75.1M $2.22B +$16M $29.55 255
2017 Q4 74.7M $2.57B -$23.8M $34.34 248
2017 Q3 75.1M $2.72B -$232M $36.18 221
2017 Q2 82M $2.12B -$23.9M $25.84 241
2017 Q1 83.6M $1.61B +$174M $19.20 234
2016 Q4 79.8M $1.33B -$62.9M $16.67 220
2016 Q3 82.7M $1.7B -$42.4M $20.58 217
2016 Q2 81.1M $2.48B -$34M $30.60 250
2016 Q1 81.8M $3.06B -$306M $37.43 228
2015 Q4 89.7M $3.87B -$60.4M $43.16 229
2015 Q3 90.4M $3.39B -$55.2M $37.48 228
2015 Q2 92.8M $3.15B -$17.8M $33.99 233
2015 Q1 92.6M $3.28B -$58.4M $35.40 250
2014 Q4 93.7M $3.19B -$80.6M $34.06 263
2014 Q3 95.4M $3.68B -$224M $38.57 270
2014 Q2 102M $3.95B -$223M $38.92 287
2014 Q1 108M $3.7B +$249M $34.19 276